Loading…
A 3mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs
Saved in:
Published in: | Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2011-01, Vol.78 (1), p.50-55 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1297-319X |
DOI: | 10.1016/j.jbspin.2010.04.017 |